Kevin Judy

4.7k total citations
110 papers, 3.3k citations indexed

About

Kevin Judy is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Kevin Judy has authored 110 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 32 papers in Pulmonary and Respiratory Medicine and 24 papers in Neurology. Recurrent topics in Kevin Judy's work include Glioma Diagnosis and Treatment (56 papers), Brain Metastases and Treatment (27 papers) and Meningioma and schwannoma management (17 papers). Kevin Judy is often cited by papers focused on Glioma Diagnosis and Treatment (56 papers), Brain Metastases and Treatment (27 papers) and Meningioma and schwannoma management (17 papers). Kevin Judy collaborates with scholars based in United States, Poland and Canada. Kevin Judy's co-authors include Donald M. O’Rourke, Elias R. Melhem, Ronald L. Wolf, Harish Poptani, John A. Detre, Sydney M. Evans, Stephen M. Hahn, Cameron J. Koch, Sanjeev Chawla and Kevin W. Jenkins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Kevin Judy

105 papers receiving 3.3k citations

Peers

Countries citing papers authored by Kevin Judy

Since Specialization

Citations

This map shows the geographic impact of Kevin Judy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Judy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Judy more than expected).

Fields of papers citing papers by Kevin Judy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Judy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Judy. The network helps show where Kevin Judy may publish in the future.

Co-authorship network of co-authors of Kevin Judy

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Judy. A scholar is included among the top collaborators of Kevin Judy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Judy. Kevin Judy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Introducing the operative value index for glioma surgery: an integration of quality-adjusted life years with time-driven activity-based costing 2025 ·Journal of Neuro-Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Simmi K. Ratan, (unknown), (unknown), (unknown), Ahmad Khan, (unknown), (unknown), (unknown), Nicolas Clark, James J. Evans, Kevin Judy, Christopher Farrell, Ahilan Sivaganesan	1
2	Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM) 2024 ·Journal of Clinical Neuroscience ·(unknown), (unknown), Christopher D. Gardner, (unknown), (unknown), (unknown), (unknown), (unknown), Kevin Judy, (unknown), Nicole L. Simone, Iyad Alnahhas, Wenyin Shi	0
3	Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes 2023 ·Neurosurgical FOCUS ·Omaditya Khanna, Anahita Fathi Kazerooni, (unknown), Aria Mahtabfar, Arbaz Momin, (unknown), (unknown), Michael P. Baldassari, Lohit Velagapudi, José García, Chiharu Sako, Christopher Farrell, James J. Evans, Kevin Judy, David Andrews, Adam E. Flanders, Wenyin Shi, Christos Davatzikos	14
4	Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma 2020 ·Journal of Neuro-Oncology ·Andrew Song, Voichita Bar‐Ad, Nina Martinez, Jon Glass, David W. Andrews, Kevin Judy, James J. Evans, Christopher Farrell, Maria Werner‐Wasik, Inna Chervoneva, Michele Ly, Joshua D. Palmer, Haisong Liu, Wenyin Shi	20
5	Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas 2019 ·Radiotherapy and Oncology ·Andrew Song, David W. Andrews, Maria Werner‐Wasik, Lyndon Kim, Jon Glass, Voichita Bar‐Ad, James J. Evans, Christopher Farrell, Kevin Judy, Constantine Daskalakis, Tingting Zhan, Wenyin Shi	24
6	Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment 2017 ·Journal of Neuro-Oncology ·Wenyin Shi, Erik Blomain, Joshua Siglin, Joshua D. Palmer, Tu Dan, Yang Wang, Maria Werner‐Wasik, Jon Glass, Lyndon Kim, Voichita Bar Ad, Deepak Bhamidipati, James J. Evans, Kevin Judy, Christopher Farrell, David W. Andrews	11
7	Phase I Study of Ipilimumab Combined With Whole-Brain Radiation Therapy or Radiosurgery for Melanoma Patients with Brain Metastases 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Noelle L. Williams, (unknown), Harriet Eldredge-Hindy, (unknown), Michael J. Mastrangelo, (unknown), (unknown), (unknown), Christopher Farrell, Kevin Judy, David W. Andrews, (unknown), Maria Werner‐Wasik, Evan Wuthrick, Weilong Shi	1
8	BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial 2015 ·Journal of Neuro-Oncology ·Stuart H. Burri, Roshan S. Prabhu, Ashley Sumrall, (unknown), (unknown), Brent E. Heideman, (unknown), (unknown), James T. Symanowski, Walter F. Wiggins, Lynn S. Ashby, H. James Norton, Kevin Judy, Anthony L. Asher	20
9	Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial 2014 ·Journal of Neuro-Oncology ·Wenyin Shi, Yaacov Richard Lawrence, Hak Choy, Maria Werner‐Wasik, David W. Andrews, James J. Evans, Kevin Judy, Christopher Farrell, Yaron A. Moshel, Adam C. Berger, Voichita Bar‐Ad, Adam P. Dicker	28
10	Predictors of Hearing Loss After Gamma Knife Radiosurgery for Vestibular Schwannomas: Age, Cochlear Dose, and Tumor Coverage 2011 ·Neurosurgery ·(unknown), Michael J. Ruckenstein, Douglas C. Bigelow, Kevin Judy, (unknown), Michelle Alonso‐Basanta, John Y. K. Lee	40
11	Concurrent Cochlear Implantation with Resection of Skull Base Hemangiopericytoma following Sudden Deafness in an Only Hearing Ear 2010 ·Skull base ·Evan R. Ransom, Kevin Judy, Douglas C. Bigelow	3
12	Biodistribution and dosimetry of 18F-EF5 in cancer patients with preliminary comparison of 18F-EF5 uptake versus EF5 binding in human glioblastoma 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Cameron J. Koch, Joshua Scheuermann, Chaitanya Divgi, Kevin Judy, Alexander V. Kachur, R. Freifelder, Janet S. Reddin, Joel S. Karp, James B. Stubbs, Stephen M. Hahn, (unknown), Deborah S. Smith, (unknown), Sydney M. Evans	48
13	Imaging and Analytical Methods as Applied to the Evaluation of Vasculature and Hypoxia in Human Brain Tumors 2008 ·Radiation Research ·Sydney M. Evans, Kevin W. Jenkins, W. Timothy Jenkins, Thomas J. Dilling, Kevin Judy, (unknown), Alexander R. Judkins, Stephen M. Hahn, Cameron J. Koch	36
14	Risk factors affecting survival after brain metastases from non—small cell lung carcinoma: a follow-up study of 70 patients 2001 ·Journal of neurosurgery ·John M. Abrahams, (unknown), Mary Putt, (unknown), Kevin Judy	35
15	Evaluation of response to gene therapy for malignant gliomas with FDG PET imaging and MRI 1998 ·Open Repository and Bibliography (University of Liège) ·Roland Hustinx, D. B. Hackney, François Bénard, Jane Β. Alavi, Stephen Eck, Kevin Judy, Prejesh Philips, Abass Alavi	1
16	Gliomas: correlation of magnetic susceptibility artifact with histologic grade. 1997 ·Radiology ·Linda J. Bagley, Robert I. Grossman, Kevin Judy, Mark Curtis, Laurie A. Loevner, Marcia Polansky, John A. Detre	52
17	Functional Activation during an Auditory Comprehension Task in Patients with Temporal Lobe Lesions 1996 ·NeuroImage ·David C. Alsop, John A. Detre, Mark D’Esposito, R S Howard, Joseph A. Maldjian, Murray Grossman, John Listerud, Eugene S. Flamm, Kevin Judy, S W Atlas	17
18	Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas 1995 ·Journal of neurosurgery ·Kevin Judy, Alessandro Olivi, (unknown), Abraham J. Domb, Jonathan I. Epstein, (unknown), Henry Brem	74
19	Proposed Toxic Oxidant Inhibitors Fail to Reduce Brain Edema 1994 ·PubMed ·Kevin Judy, G. B. Bulkley, Bo E. Hedlund, Donlin M. Long	2
20	The application of 5-bromodeoxyuridine in the management of CNS tumors 1994 ·Journal of Neuro-Oncology ·Andrew Freese, Donald M. O’Rourke, Kevin Judy, Michael J. O’Connor	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact